Agilon Health Inc. reported a net income of $12.1 million, or $0.03 per share, for the first quarter ended March 31, 2025, exceeding analyst expectations for a loss of $0.01 per share. Adjusted earnings came in at less than $0.01 per share.
Total revenues for the quarter were $1.53 billion, surpassing Street forecasts of $1.51 billion. However, this figure represents a 4.5% decrease compared to $1.60 billion in the first quarter of 2024, indicating a year-over-year revenue decline.
For the second quarter of 2025, Agilon Health expects revenues to be in the range of $1.44 billion to $1.51 billion. The company also updated its full-year 2025 revenue guidance to between $5.85 billion and $6.03 billion.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.